The Peptide Gold Rush Is Coming
HealthThe Peptide Gold Rush Is ComingPopular gray-market drugs may soon be easy to get through mainstream channels.By Tom BartlettIllustration by The Atlantic. Source: Getty.July 24, 2026, 11:19 AM ET ShareSave BPC-157 is rumored to heal almost anything: a sore shoulder, a bum knee, a pulled hamstring, ulcerative colitis. Maybe even traumatic brain injuries and multiple sclerosis, too.
- ▪HealthThe Peptide Gold Rush Is ComingPopular gray-market drugs may soon be easy to get through mainstream channels.By Tom BartlettIllustration by The Atlantic.
- ▪Source: Getty.July 24, 2026, 11:19 AM ET ShareSave BPC-157 is rumored to heal almost anything: a sore shoulder, a bum knee, a pulled hamstring, ulcerative colitis.
- ▪Maybe even traumatic brain injuries and multiple sclerosis, too.
The Atlantic files mainly under culture. We currently carry 311 of its stories.
Opening excerpt (first ~120 words) tap to expand
HealthThe Peptide Gold Rush Is ComingPopular gray-market drugs may soon be easy to get through mainstream channels.By Tom BartlettIllustration by The Atlantic. Source: Getty.July 24, 2026, 11:19 AM ET ShareSave BPC-157 is rumored to heal almost anything: a sore shoulder, a bum knee, a pulled hamstring, ulcerative colitis. Maybe even traumatic brain injuries and multiple sclerosis, too. The drug—part of a class called peptides—has been around for decades. But it has recently experienced a surge in popularity, thanks in part to great peptide publicity from influencers, podcasters, and Robert F. Kennedy Jr., the secretary of health and human services. Thousands of Americans are taking it.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Atlantic.
Discussion
0 commentsMore from The Atlantic
